yahoo/ap reports today on a strongly-worded JAMA piece on guest authorship and ghostwriting in publications related to rofecoxib. from lindsey tanner’s associated press article: CHICAGO (AP) — Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. The reports claim Merck & Co. … Continue reading a practice called ghostwriting